Clinical Trial Update: Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of abatacept and cyclophosphamide for lupus nephritis completed with results posted in 2014. The conditions st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• Abatacept (abatacept)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Lupus Nephritis, Lupus Erythematosus, Systemic | Phase 2 | Status: COMPLETED | Results posted: 2014-10-09